company background image
AJANTPHARM logo

Ajanta Pharma NSEI:AJANTPHARM Rapporto sulle azioni

Ultimo prezzo

₹3.08k

Cap. di mercato

₹385.8b

7D

1.0%

1Y

74.2%

Aggiornato

21 Aug, 2024

Dati

Dati finanziari dell'azienda +

Ajanta Pharma Limited

NSEI:AJANTPHARM Rapporto sulle azioni

Cap. di mercato: ₹385.8b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

AJANTPHARM Panoramica delle azioni

Ajanta Pharma Limited, società di formulazione di specialità farmaceutiche, insieme alle sue controllate, sviluppa, produce e commercializza dosaggi finiti di specialità farmaceutiche.

Informazioni sull'azienda

AJANTPHARM analisi fondamentale
Punteggio fiocco di neve
Valutazione1/6
Crescita futura3/6
Prestazioni passate6/6
Salute finanziaria6/6
Dividendi5/6

Premi

Si prevede che gli utili cresceranno del 14.39% all'anno
Gli utili sono cresciuti del 37.4% nell'ultimo anno

Analisi del rischio

Andamento instabile dei dividendi

Ajanta Pharma Limited Concorrenti

Ipca Laboratories

NSEI:IPCALAB

₹356.8b

Gland Pharma

NSEI:GLAND

₹317.9b

J. B. Chemicals & Pharmaceuticals

BSE:506943

₹298.7b

Abbott India

BSE:500488

₹606.6b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Ajanta Pharma
Prezzi storici delle azioni
Prezzo attuale dell'azione₹3,077.65
Massimo di 52 settimane₹3,389.85
Minimo di 52 settimane₹1,650.05
Beta0.046
1Variazione di 1 mese34.13%
Variazione a 3 mesi28.13%
Variazione di 1 anno74.20%
3Variazione a 3 anni105.14%
Variazione a 5 anni368.18%
Variazione dall'IPO19,550.15%

Notizie e aggiornamenti recenti

Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 04
Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

Aug 01
Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

Recent updates

Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 04
Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

Aug 01
Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case

Jun 01
With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case

Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

May 05
Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price

Apr 05
Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price

We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Feb 23
We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected

Dec 23
Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected

Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

Aug 26
Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well

Feb 07
These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well

Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Oct 24
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Aug 25
Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?

Jul 19
Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?

A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Apr 28
A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

Mar 14
Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut

Feb 06
I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut

Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Dec 13
Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Oct 31
Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching

Sep 22
Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching

Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?

Sep 08
Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?

Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?

Aug 26
Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?

Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet

Jul 07
Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet

Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?

Jun 14
Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?

Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?

May 15
Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?

Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 10
Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why

Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Mar 11
Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?

Feb 24
Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?

The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On

Jan 30
The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On

What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?

Jan 18
What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?

Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Jan 06
Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

What Percentage Of Ajanta Pharma Limited (NSE:AJANTPHARM) Shares Do Insiders Own?

Dec 25
What Percentage Of Ajanta Pharma Limited (NSE:AJANTPHARM) Shares Do Insiders Own?

You Have To Love Ajanta Pharma Limited's (NSE:AJANTPHARM) Dividend

Dec 13
You Have To Love Ajanta Pharma Limited's (NSE:AJANTPHARM) Dividend

Is Ajanta Pharma Limited's (NSE:AJANTPHARM) Recent Stock Performance Influenced By Its Financials In Any Way?

Dec 01
Is Ajanta Pharma Limited's (NSE:AJANTPHARM) Recent Stock Performance Influenced By Its Financials In Any Way?

With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Is Interesting

Nov 19
With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Is Interesting

Rendimenti per gli azionisti

AJANTPHARMIN PharmaceuticalsIN Mercato
7D1.0%1.7%2.6%
1Y74.2%52.7%43.8%

Ritorno vs Industria: AJANTPHARM ha superato il Indian Pharmaceuticals che ha restituito 52.7 % nell'ultimo anno.

Rendimento vs Mercato: AJANTPHARM ha superato il mercato Indian che ha restituito 43.8 % nell'ultimo anno.

Volatilità dei prezzi

Is AJANTPHARM's price volatile compared to industry and market?
AJANTPHARM volatility
AJANTPHARM Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.8%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.4%

Prezzo delle azioni stabile: Il prezzo delle azioni di AJANTPHARM è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 5% ) di AJANTPHARM è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
19738,073Yogesh Agrawalwww.ajantapharma.com

Ajanta Pharma Limited, società di formulazione di specialità farmaceutiche, insieme alle sue controllate, sviluppa, produce e commercializza dosaggi finiti di specialità farmaceutiche. L'azienda commercializza e serve vari segmenti terapeutici, quali cardiologia, antidiabetico, oftalmologia, dermatologia, gestione del dolore e aree respiratorie. Fornisce inoltre compresse, capsule, prodotti iniettabili, inalatori, unguenti, creme e liquidi.

Ajanta Pharma Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Ajanta Pharma con la sua capitalizzazione di mercato?
AJANTPHARM statistiche fondamentali
Capitalizzazione di mercato₹385.78b
Guadagni(TTM)₹8.54b
Ricavi(TTM)₹43.33b

45.2x

Rapporto P/E

8.9x

Rapporto P/S

AJANTPHARM è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
AJANTPHARM Conto economico (TTM)
Ricavi₹43.33b
Costo del fatturato₹11.37b
Profitto lordo₹31.96b
Altre spese₹23.42b
Guadagni₹8.54b

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)68.11
Margine lordo73.76%
Margine di profitto netto19.71%
Rapporto debito/patrimonio netto1.0%

Come si è comportato AJANTPHARM nel lungo periodo?

Vedi performance storica e confronto

Dividendi

1.2%

Rendimento attuale del dividendo

38%

Rapporto di remunerazione